Bayer EPS - Earnings per Share 2010-2024 | BAYRY

Bayer earnings per share (EPS) for the twelve months ending December 31, 2024 was $-0.70, a 13% decline year-over-year.

  • Bayer EPS for the quarter ending December 31, 2024 was $0.43, a 11.37% increase year-over-year.
  • Bayer 2024 annual EPS was $-0.7, a 13.1% decline from 2023.
  • Bayer 2023 annual EPS was $-0.81, a 172.75% decline from 2022.
  • Bayer 2022 annual EPS was $1.11, a 268.21% increase from 2021.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.

Bayer EPS - Earnings per Share 2010-2024 | BAYRY

  • Bayer EPS for the quarter ending December 31, 2024 was $0.43, a 11.37% increase year-over-year.
  • Bayer 2024 annual EPS was $-0.7, a 13.1% decline from 2023.
  • Bayer 2023 annual EPS was $-0.81, a 172.75% decline from 2022.
  • Bayer 2022 annual EPS was $1.11, a 268.21% increase from 2021.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$796.4B
Johnson & Johnson (JNJ)$379.5B
AbbVie (ABBV)$306B
Novo Nordisk (NVO)$260.6B
Roche Holding AG (RHHBY)$248.1B
Novartis AG (NVS)$234.2B
Merck (MRK)$196.7B
Sanofi (SNY)$128.6B
Pfizer (PFE)$125.6B
Innoviva (INVA)$1.1B